HF
NAMS icon

HRT Financial’s NewAmsterdam Pharma NAMS Stock Holding History

HRT Financial’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Buy
+349,843
New +$11.5M 0.02% 700
2025
Q3 		– Sell
-26,208
Closed -$474K – 3396
2025
Q2 		$474K Sell
26,208
-6,434
-20% -$117K ﹤0.01% 1632
2025
Q1 		$668K Buy
+32,642
New +$726K ﹤0.01% 1312
2024
Q4 		– Sell
-37,601
Closed -$624K – 2953
2024
Q3 		$624K Buy
+37,601
New +$651K ﹤0.01% 1485

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

HRT Financial's NAMS Position: Q2 2026 in Review

HRT Financial opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 349,843 shares worth $11.9M. The stake represents 0.02% of the portfolio and ranks #700 among its holdings. This is a return to the name: HRT Financial previously reported a position in NAMS as recently as Q2 2025.

HRT Financial first reported a position in NAMS in Q3 2024 and has held it in 4 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • HRT Financial held 349,843 shares of NewAmsterdam Pharma worth $11.9M as of Q2 2026.
  • NewAmsterdam Pharma was a new HRT Financial position in Q2 2026.
  • NewAmsterdam Pharma made up 0.02% of HRT Financial's portfolio in Q2 2026, its #700 holding.
  • HRT Financial first reported a position in NewAmsterdam Pharma in Q3 2024 and has held it in 4 quarters since.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.